Xiaowen Wang presents PBPK research at SOT 2026

Xiaowen Wang attended the 2026 Society of Toxicology (SOT) Annual Meeting for the first time. She presented work integrating a physiologically based pharmacokinetic (PBPK) model with intra-arterial drug delivery (I-ADD) for brain tumor therapy, in collaboration with Dr. Zagha’s Lab.
Her work received two recognitions:
- Drug Discovery Toxicology Specialty Section (DDTSS) Student Abstract Award, 3rd Place.
- Biological Modeling Specialty Section (BMSS) Honorable Mention.

Source: Legacy announcement
Source notes
- Exact news/event date is not provided. Year is retained only where explicitly stated.
- Index claims three recognitions; detail names only DDTSS third place and BMSS honorable mention. Homepage summary omits the inconsistent count.
- The PI supplied and approved both photos for this article. The award-photo screen reads 2025; that label remains unresolved and has not been edited. The poster photo is used as the primary image.